oa SA Pharmaceutical Journal - New drug focus
|Article Title||New drug focus|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||Oct 2006|
Extracted from text ... SA Pharmaceutical Journal - October 2006 46 DRUG INFO Information supplied by Amayeza Info Services Tel : (011) 678 2332 Stresam(r) - A new nonbenzodiazepine for anxiety Approved indication Etifoxine (Stresam(r)) is indicated for the short-term treatment of the psychosomatic manifestations of anxiety. It treats both the psychological and the somatic (functional) consequences of anxiety. Mode of action Etifoxine is structurally unrelated to the benzodiazepines. Chemically, it is a benzoxazine that has a dual action on gamma amino butyric acid (GABA) and works both by interacting with the chloride channel of GABAA receptors and also by increasing GABAergic neurotransmission. Etifoxine ..
Article metrics loading...